Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Hongren Pharmaceutical is a Chinese pharmaceutical company dedicated to the research, development, and large-scale manufacturing of chemical drugs and traditional Chinese medicine (TCM) preparations. Based in the Baiyun District of Guangzhou, the company operates modern, GMP-certified production facilities for a variety of dosage forms including capsules, tablets, and granules. Its commercial portfolio is primarily focused on over-the-counter (OTC) and prescription medications for respiratory health, infectious diseases, and nutritional supplementation. By combining traditional herbal expertise with modern pharmaceutical standards, the company provides essential healthcare products to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Hongren Pharmaceutical.